000			01950 a2200577 4500
005			20250516163130.0
264		0	_c20150511
008			201505s 0 0 eng d
022			_a2050-6511
024	7		_a10.1186/2050-6511-14-40 _2doi
040			_aNLM _beng _cNLM
100	1		_aUrien, Saik
245	0	0	_aAnakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes. _h[electronic resource]
260			_bBMC pharmacology & toxicology _cAug 2013
300			_a40 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAlgorithms
650	0	4	_aArthritis, Juvenile _xdrug therapy
650	0	4	_aC-Reactive Protein _xmetabolism
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHereditary Autoinflammatory Diseases _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aInjections, Subcutaneous
650	0	4	_aInterleukin 1 Receptor Antagonist Protein _xpharmacokinetics
650	0	4	_aMale
650	0	4	_aMetabolic Clearance Rate
650	0	4	_aModels, Biological
650	0	4	_aProspective Studies
650	0	4	_aSyndrome
650	0	4	_aTissue Distribution
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aBardin, Christophe
700	1		_aBader-Meunier, Brigitte
700	1		_aMouy, Richard
700	1		_aCompeyrot-Lacassagne, Sandrine
700	1		_aFoissac, Franz
700	1		_aFlorkin, Benoît
700	1		_aWouters, Carine
700	1		_aNeven, Bénédicte
700	1		_aTreluyer, Jean-Marc
700	1		_aQuartier, Pierre
773	0		_tBMC pharmacology & toxicology _gvol. 14 _gp. 40
856	4	0	_uhttps://doi.org/10.1186/2050-6511-14-40 _zAvailable from publisher's website
999			_c22975791 _d22975791